Clinical Trial Detail

NCT ID NCT03209401
Title Niraparib Plus Carboplatin in Patients With Homologous Recombination Deficient Advanced Solid Tumor Malignancies
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Georgetown University
Indications

Advanced Solid Tumor

Therapies

Carboplatin + Niraparib

Age Groups: senior adult

Additional content available in CKB BOOST